This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Richard Hargreaves: Innovator in Migraine Treatment
Introduction
Richard Hargreaves is a notable inventor based in Terlings Park, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of migraines. His innovative approach combines a 5HT agonist and a COX-2 selective inhibitor, showcasing his commitment to improving patient care.
Latest Patents
Hargreaves holds a patent for a method of treating migraines and pharmaceutical compositions. This patent highlights the effectiveness of his combination therapy in the treatment and prevention of migraine, which is a common and debilitating condition.
Career Highlights
Richard Hargreaves is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to focus on developing groundbreaking treatments that address significant health challenges.
Collaborations
Throughout his career, Hargreaves has collaborated with talented professionals, including Kremena Simitchieva and Scott A Reines. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Richard Hargreaves is a dedicated inventor whose work in migraine treatment exemplifies innovation in the pharmaceutical industry. His contributions continue to impact the lives of many individuals suffering from migraines.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile